table of content
1 Study Coverage
1.1 Equine Rabies Immunoglobulin (ERIG) Product Introduction
1.2 Market by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Market by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts 2017-2028
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Estimates and Forecasts 2017-2028
2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
2.4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2022)
2.4.2 Global Sales Equine Rabies Immunoglobulin (ERIG) by Region (2023-2028)
2.5 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region
2.5.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2022)
2.5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers
3.1.1 Global Top Equine Rabies Immunoglobulin (ERIG) Manufacturers by Sales (2017-2022)
3.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Equine Rabies Immunoglobulin (ERIG) in 2021
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Manufacturers (2017-2022)
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Equine Rabies Immunoglobulin (ERIG) Revenue in 2021
3.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Type (2017-2022)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Type (2023-2028)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2017-2028)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Type (2017-2022)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2017-2028)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type
4.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2017-2022)
4.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Sales by Application (2017-2022)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Sales by Application (2023-2028)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2017-2028)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Historical Revenue by Application (2017-2022)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2017-2028)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application
5.3.1 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2017-2022)
5.3.2 Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
6.1.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
6.1.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
6.2 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
6.2.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
6.2.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
6.3 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
6.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
6.3.2 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Type
7.1.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
7.1.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
7.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Application
7.2.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
7.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
7.3 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country
7.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
7.3.2 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Type
8.1.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
8.1.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
8.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Application
8.2.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
8.2.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
8.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Region
8.3.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2017-2028)
8.3.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Type
9.1.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
9.1.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
9.2 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Application
9.2.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
9.2.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
9.3 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country
9.3.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
9.3.2 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Type
10.1.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2017-2028)
10.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Application
10.2.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2017-2028)
10.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country
10.3.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Serum China
11.1.1 Serum China Corporation Information
11.1.2 Serum China Overview
11.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Serum China Recent Developments
11.2 Lanzhou Institute of Biological Products
11.2.1 Lanzhou Institute of Biological Products Corporation Information
11.2.2 Lanzhou Institute of Biological Products Overview
11.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lanzhou Institute of Biological Products Recent Developments
11.3 Wuhan Institute of Biological Products
11.3.1 Wuhan Institute of Biological Products Corporation Information
11.3.2 Wuhan Institute of Biological Products Overview
11.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Institute of Biological Products Recent Developments
11.4 Premium Serums
11.4.1 Premium Serums Corporation Information
11.4.2 Premium Serums Overview
11.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Premium Serums Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Bharat Serums
11.6.1 Bharat Serums Corporation Information
11.6.2 Bharat Serums Overview
11.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Serums Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
12.2 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
12.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
12.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
12.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
12.5 Equine Rabies Immunoglobulin (ERIG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
13.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
13.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
13.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
14 Key Findings in The Global Equine Rabies Immunoglobulin (ERIG) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
